Enter your keyword

Efficiently Creating Value with Innovative Science

Press Release

Mar 30, 2005
OXiGENE to Present at Lehman Brothers Eighth Annual Global HealthCare Conference: April 1st Presentation Available via Live Webcast
OXiGENE to Present at Lehman Brothers Eighth Annual Global HealthCare Conference: April 1st Presentation Available via Live Webcast WALTHAM, Mass.--(BUSINESS WIRE)--March 30, 2005--OXiGENE, Inc. (NASDAQ: OXGN) (XSSE: OXGN), a leading developer of biopharmaceutical compounds designed to target aberrant blood vessels within solid tumor cancers and ocular neovascular diseases, today announced that President and Chief Executive Officer Fred Driscoll will present at Lehman Brothers Eighth Annual Global HealthCare Conference, at the Loews Miami Beach Hotel, Miami, Florida. The conference takes place March 30 - April 1.

The Lehman Brothers presentation is scheduled to begin at 11:15 ET Friday, April 1, 2005. A live and archived webcast will be available on OXiGENE's website, www.oxigene.com. From the home page, click on the "Calendar of Events" link under the tab labeled "Press Room". Please log on five minutes prior to the event to ensure the proper software is downloaded and installed.

About OXiGENE, Inc.

OXiGENE is an emerging pharmaceutical company developing novel small-molecule therapeutics to treat cancer and eye diseases. The Company's major focus is the clinical advancement of drug candidates that selectively disrupt abnormal blood vessels associated with solid tumor progression and visual impairment. OXiGENE is dedicated to leveraging its intellectual property position and therapeutic development expertise to bring life saving and enhancing medicines to patients.

CONTACT: OXiGENE Inc.
James Murphy, 781-547-5900
Vice President and CFO
jmurphy@oxigene.com
or
MacDougall BioCommunications
Chris Erdman, 508-647-0209
Vice President
chris@macbiocom.com

SOURCE: OXiGENE Inc.